• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceProspera Spinal Cord Stimulation (SCS) System, Resilience Percutaneous Lead, HomeStream Remote Management
Generic NameStimulator, spinal-cord, totally implanted for pain relief
ApplicantBiotronik Nro, Inc.
6024 Jean Rd.
Lake Oswego, OR 97035
PMA NumberP210037
Supplement NumberS011
Date Received04/04/2025
Decision Date06/25/2025
Product Code LGW 
Advisory Committee Neurology
Supplement TypeNormal 180 Day Track
Supplement Reason Change Design/Components/Specifications/Material
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
approval for changes made to the Prospera SCS System embedded software (implant software [ISW]) and Neuro Service Center (NSC). Specifically, the Prospera SCS System embedded software (ISW) was updated to version 1.0.3, which included changes to the lead impedance measurements algorithm to provide more information during intraoperative testing and improve the accuracy of calculation of resistive measurements. The NSC was updated to version 1.6.3, which included changes to allow magnetic resonance imaging (MRI) mode entry if the automated lead impedance measurements are within range for the three most recent days and the consideration of touching leads condition as safe for MRI.
-
-